IF all over again

If you can meet with Triumph and Disaster
And treat those two impostors just the same;
If you can bear to hear the truth you’ve spoken
Twisted by knaves to make a trap for fools,
Or watch the things you gave your life to, broken,
And stoop and build ’em up with worn-out tools:
Rudyard Kipling

Yes it is that time of the year again when Thomson Reuters publishes its Journal Citation Report (JCR) and everyone involved in science publishing gets obsessed with Impact Factors (IF). I’m not going to go through the arguments about how little Impact Factors really mean, and I’m certainly not going to try and forecast the health or otherwise of a publishing venture based on a change of 0.3 in its IF. But I thought you might want to know what Nature Protocols’s 2012 IF is. So cue drum roll …

It’s 7.96 down a couple of points from last year’s 9.92

Or

It’s 11.74 up from last year’s 10.20

Nothing is simple when it comes to Impact Factors. They are sort of an estimate of the average number of citations that a paper in a particular journal gets, but they are actually the number of citations a journal gets in a year to articles published in the previous two (or five) years divided by the number of articles published in those years that it seem appropriate to cite (‘simples!’). Herein lies the apparent contradiction in the numbers I gave above. Nature Protocol’s Impact Factor based on citations in 2012 to protocols published in 2010 and 2011–the two year impact factor (IF2)– is 7.96. The Impact factor based on citations in 2012 to protocols published between 2007 and 2011–the five year Impact Factor (IF5)–is 11.74.

For most journals there isn’t a whole lot of difference between the IF2 and the IF5, certainly less than 10% so when someone says Impact Factor they normally mean IF2. There are a few journals with big differences between the two values. The journal with the highest IF2 of all, CA: A Cancer Journal for Clinicians published by the American Cancer Society, has an IF2 of 153.46 and a IF5 of 88.55 which I interpret as meaning that what it publishes is extremely relevant for a couple of years (and so is highly cited) but after that it quickly loses its importance.

Conversely that Nature Protocols has a higher IF5 than IF2 could be taken as an indication that the protocols we publish remain relevant well beyond the first years after presentation. A measure that might bear that out would be the cited half-life of the journal. This is defined as the median age of the articles published in Nature Protocols that were cited in a given year (i.e. 2012). For Nature Protocols it is 4.9 (in 2011 it was 4.2), but that really doesn’t say a lot as Nature Protocols is a relatively young journal which has only been in existence since 2006. The maximum value for cited half-life we could have got would have been 6 and if there was no change in the rate of citation of our protocols over time a value of 3 would have been expected. We will need to be at least in our teens before I will put much store by cited half-life.

There is another confounding factor in all this for Nature Protocols and its name is DAVID.

In December 2008 we published online a protocol by Richard Lempicki and colleagues at National Cancer Institute at Frederick, Maryland called “Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources” (Nature Protocols 4, 44-57 doi:10.1038/nprot.2008.211 (2009)). It is our most cited paper having been cited more than 3,000 times. It is in fact the most highly cited paper from any Nature  journal, including Nature itself, published in 2009 (yes I know it was published in 2008 but it was in the January 2009 issue of the journal and so that makes it officially a 2009 paper). In 2012 alone it was cited upwards of 1,000 times. However since it was published in 2009 those citation do not contribute to our  IF2 although they do to our  IF5. It is difficult to get the figures to calculate the exact effect of a single paper on IF but a fair approximation would be to say that had those 1,000 citations been included in the calculation of our IF2 then it would have been a bit less than 3 points higher, while excluding them from our  IF5 would reduce that by about 0.8 making both values in the region of 10.9.

Yep, you’ve got it! Citations to a single paper seem to account for all the difference in our Impact Factors. Which simply shows again that IF may be a great poem, but it is a poor measure of the scientific literature.

 

All The Old Showstoppers

Now is the time of the month when I have to look at “the numbers” to see how things are going on Nature Protocols and Protocol Exchange. Since I was doing that anyway I thought I’d share some with you. The thing that most intrigues me is what brings people to the sites; what questions are they trying to answer? Well here are the top 20 search terms that resulted in people coming to Nature Protocols and Protocol Exchange in the last month (linked to the Protocols I imagine they found helpful).

Nature Protocols

  1. nature protocols
  2. nature protocol
  3. multiplex pcr
  4. “clonogenic assay “:https://www.nature.com/nprot/journal/v1/n5/abs/nprot.2006.339.html
  5. overlap extension pcr
  6. blue native page
  7. inverse pcr
  8. rolling circle amplification
  9. pyrosequencing
  10. pulsed field gel electrophoresis
  11. site directed mutagenesis
  12. scratch assay
  13. circular dichroism
  14. srb assay
  15. overlap pcr
  16. touchdown pcr
  17. trail making test
  18. cell culture
  19. chromatin immunoprecipitation
  20. qpcr

Not so informative really apart from showing that a lot of people need help with their PCR. I’m also surprised that there is so much interest in circular dichroism. But those looking for information are very persistent as the page I assume they are coming to (Using Circular Dichroism Spectra to Estimate Protein Secondary Structure) was on the third page of Google’s search results.

How about the Protocol Exchange:

  1. itraq
  2. transwell migration assay
  3. barnes maze
  4. kaiser test
  5. nature protocols
  6. neurosphere
  7. neurosphere assay
  8. slic cloning
  9. fluorescent in situ hybridization protocol
  10. dpph assay protocol
  11. immunofluorescence protocol
  12. chip assay
  13. nature protocol exchange
  14. transient transfection
  15. transwell assay
  16. in utero electroporation
  17. neurospheres
  18. protocol exchange
  19. purify protein complex
  20. fluorescence in situ hybridization protocol

That’s a much more diverse list of searches. But there certainly is a desire to know about iTRAQ (which stands for isobaric peptide Tags for Relative and Absolute Quantification if you were in any doubt), and the Protocol Quantitative analysis of protein expression using iTRAQ and mass spectrometry by Ry Y Tweedie-Cullen & Magdalena Livingstone-Zatchej will hopefully have satisfied them.